Public Health & Education - GSK Applies for WHO Prequalification of HPV Vaccine Cervarix
GlaxoSmithKline recently applied for World Health Organization prequalification review of its human papillomavirus vaccine Cervarix for by with the aim of expediting the drug's sale to women in developing countries, Business Daily Africa reports (Aron, Business Daily Africa, 10/9). Cervarix has been shown to
www.kaisernetwork.org/daily_reports/rep_index.cfm?hint=2&DR_ID=48116
|
2007-10-11
|
Powered by Google Search Appliance
| |